Clinical Trials Logo

Prolapse clinical trials

View clinical trials related to Prolapse.

Filter by:

NCT ID: NCT06404931 Not yet recruiting - Prolapse; Female Clinical Trials

Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment

Start date: May 1, 2024
Phase: Phase 2
Study type: Interventional

This is a randomised study in which we compare the effectiveness of three different procedures in mending symptomatic anterior and apical prolapse in patients who are candidates to receive surgery. They will be randomly assigned in a ratio 1:1:1 to three different groups who will have assigned three different kinds of surgery. In the patients of the first group a classic vaginal hysterectomy with anterior colporrhaphy will be practised. Patients who belong to group two will undergo a vaginal hysterectomy followed by placement of an acellular dermal matrix from cadaveric donors (hADM) for anterior reinforcement and sacrospinous fixation with Anchorsure® device (Neomedic trade mark (TM) International, Spain). Finally, patients from group three will have vaginal hysterectomy followed by sacrospinous fixation with Anchorsure® alone . Patients will be followed-up at 4 weeks, 6 months, 12 months and annually till 36 months to evaluate relapses and possible complications.

NCT ID: NCT06391372 Not yet recruiting - Menopause Clinical Trials

Effect of Local Estriol Treatment Before Vaginal Repair Surgery

Start date: April 2024
Phase: Phase 3
Study type: Interventional

The aim of the study is to evaluate the effects of local estriol treatment applied before vaginal repair surgery on steroid receptors, inflammatory cell response, vascular, connective and nervous tissues in the vagina, and its effects on early postoperative period pelvic floor functions, satisfaction with the surgery and vaginal health.

NCT ID: NCT06378996 Recruiting - Clinical trials for Ventricular Arrythmia

Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring

ALARM-PILOT
Start date: May 2024
Phase: N/A
Study type: Interventional

Mitral valve prolapse (MVP) affects up to 3% of the general population and a small subset of patients is at risk for ventricular arrhythmias. This subgroup is referred to as AMVP (arrhythmic MVP) and was recently defined using the following criteria: (1) Presence of MVP), (2) Ventricular arrhythmia that is either frequent (≥5% total premature ventricular contraction (PVC) burden on Holter) or complex (non-sustained ventricular tachycardia (nsVT), ventricular tachycardia (VT), or ventricular fibrillation (VF)), and (3) The absence of any other well-defined arrhythmic substrate. Currently, diagnosis is often based on repeated 24-hour Holter monitoring. However, the ventricular arrhythmia burden varies from day-to-day and long-term rhythm monitoring has shown in other pathologies to increase the diagnostic yield with up to 200% (from 22.5% on 24h to 75.3% on 14 days). This pilot study aims to study the diagnostic yield of long-term rhythm monitoring in patients with MVP as well as the day-to-day variability of ventricular arrhythmias to facilitate power calculation for a future large-scale prospective registry.

NCT ID: NCT06372340 Not yet recruiting - Clinical trials for Urinary Incontinence

Intelligent Diagnosis and Treatment System for Pelvic Floor Dysfunction in Elderly Women

Start date: April 30, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to propose an intelligent diagnosis and treatment system for for pelvic floor dysfunction in elderly women. The main question it aims to answer: 1) How can the investigators find out early if older women have different pelvic floor muscle functions? 2)How can the investigators give personalized treatment plans based on differences in pelvic floor function? Participants will be assigned different training programs by the system. The investigators will compare the treatment effects and costs of older women with pelvic floor dysfunction using and not using the system. All the participants will be offered examinations for pelvic floor function and different treatments. All examinations and treatments are non-invasive.

NCT ID: NCT06369857 Recruiting - Clinical trials for Pelvic Organ Prolapse

Pectopexy for Apical Prolapse Management

Start date: May 9, 2024
Phase: N/A
Study type: Interventional

This study was designed to evaluate the efficacy of pectopexy for treatment of apical pelvic organ prolapse at follow up at 12 months. Investigator also evaluates complications, improvement of symptoms, quality-of-life outcomes and patient satisfaction with surgery. Assessment of restoration of normal pelvic anatomy and lower urinary tract symptoms using transperineal ultrasound

NCT ID: NCT06363903 Recruiting - Clinical trials for Pelvic Organ Prolapse

ASIA-Mesh: a Pilot Study for Diagnostics and Treatment on ASIA Syndrome Caused by Polypropylene Mesh Implantation

Start date: May 9, 2022
Phase:
Study type: Observational

In the present pilot study, a possible relation between the implantation of PP mesh for inguinal hernia, vaginal prolapse and SUI repair and subsequent systemic auto-immune complaints is investigated by testing immunologic and allergic responses in fifty patients with suspected ASIA syndrome. Additional value of MAT is investigated and effectiveness of (partial) PP mesh removal for these complaints is assessed. If so, a profound insight in diagnostics and treatment for systematic complaints will be attained that may provide opportunities for future diagnostics.

NCT ID: NCT06363838 Completed - Clinical trials for Pelvic Organ Prolapse

Evaluation of Neuromuscular Morphometry of the Vaginal Wall

Start date: December 1, 2019
Phase:
Study type: Observational

In this prospective study, women aged between 40 and 75 years who had not undergone any vaginal surgery and had not undergone any abdominal prolapse surgery were included. Thirty-one women diagnosed with rectocele on examination were included in the study group. Thirty-one patients who underwent vaginal intervention and hysterectomy for reasons other than rectocele (colposcopy, conization, etc.) without anterior or posterior wall prolapse were included in the control group.

NCT ID: NCT06359470 Completed - Clinical trials for Disc Prolapse With Radiculopathy

the Modified Reversed Contralateral Axial Rotation Position

Start date: November 5, 2022
Phase: N/A
Study type: Interventional

This study aimed to investigate the effect of specific three-dimensional (3D) positions of the trunk on patients with lumbar discogenic pain with radiculopathy aiming to find a position that directly decompresses the impinged root as well as the effect of this position on the CSA of the L3-L4, L4-L5 and L5-S1 intervertebral foramen (IVF) using 3D-CT scan imaging of the real spine

NCT ID: NCT06353230 Completed - Rectal Prolapse Clinical Trials

Comparison of Sclerotherapy Agents Used for Rectal Prolapse Treatment in Children

Prolapse
Start date: October 15, 2019
Phase: N/A
Study type: Interventional

Introduction Patients with rectal prolapse are treated with injection sclerotherapy, which is the most often used first-line surgical technique. Injection sclerotherapy has a success rate of 90-100% in youngsters, according to certain studies. Objective To compare the outcome of injection sclerotherapy using 5% Phenol in almond oil, 15% hypertonic saline and 50% dextrose water in the treatment of rectal prolapse in children.

NCT ID: NCT06352112 Completed - Clinical trials for Pelvic Floor Disorders

Effects of the Hypopressive Exercises in Women With Pelvic Organ Prolapse

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

The aim of this study was compare home-based pelvic floor muscle training (PFMT) alone and home-based PFMT combined with hypopressive exercise (HE) in terms of pelvic floor muscle (PFM) activation and severity of pelvic floor dysfunction (PFD) in women with pelvic organ prolapse (POP) for eight weeks. For this purpose, the participants were randomly divided into two groups: [PFMT alone (n:15) and PFMT combined with HE(n:17)]. DuoBravo EMG device for evaluation of PFM activation and "Pelvic Floor Distress Inventory-20" was used to evaluate the severity of PFD. All evaluations were performed twice in total, at baseline and at week 8.